Nemolizumab Shows Sustained Response up to Three Years in Atopic Dermatitis
Long-term data report sustained nemolizumab response in moderate-to-severe atopic dermatitis patients treated for up to three years, per a Business Wire release.
Topic
Long Term Data
Topic